News_第16页_Shenyang Dasan Pharmaceutical Technology Co., Ltd.

Home


Distinguish	Title	Data
Industry	NMPA Releases Draft Annual Drug Reporting Regulations and Template for Public Comment	2020-12-11
Company	Our Client Daewon Pharm Receives "Clinical Trial Approval Notice" for Pelubiprofen Extended-Release Tablets	2020-12-11
Company	Our Client Fuzhou Minhai Pharmaceutical Receives "Clinical Trial Approval Notice" for Roxatidine Acetate Hydrochloride Sustained-Release Capsules	2020-11-26
Industry	Wu Zunyou: More Evidence Suggests Imported Cold-Chain Products May Be the Source of China's Outbreaks	2020-11-12
Company	Shenyang Dasan and Korea Dasan Hold Video Conference	2020-11-12
Industry	Third Round of National Volume-Based Procurement to Be Implemented in November	2020-10-30
Industry	Will stricter rules curb API monopolies that have long plagued drug prices?	2020-10-16
Company	Go, Interns! – Internship Information Session	2020-10-16
Industry	CDE Issues Re-Registration Rules for Overseas Drugs: 120-Day Review	2020-09-23
Company	Shenyang Dasan and Korea Dasan Establish Joint Venture	2020-09-23
Industry	MIIT Authoritatively Releases 2019 Top 100 Pharmaceutical Enterprises in China Ranking	2020-08-31
Industry	CDE Releases Technical Guideline on Process Research for Traditional Chinese Medicine Compound Preparations (Draft for Comments)	2020-08-31